Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sox3
|
ENSMUSG00000045179.8 | SRY (sex determining region Y)-box 3 |
Sox10
|
ENSMUSG00000033006.9 | SRY (sex determining region Y)-box 10 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_60893047_60893392 | Sox3 | 211 | 0.719140 | 0.82 | 1.9e-14 | Click! |
chrX_60889945_60890107 | Sox3 | 3404 | 0.199471 | 0.75 | 5.0e-11 | Click! |
chrX_60892687_60892954 | Sox3 | 610 | 0.517926 | 0.69 | 4.3e-09 | Click! |
chrX_60891972_60892372 | Sox3 | 1258 | 0.343117 | 0.62 | 4.9e-07 | Click! |
chrX_60892476_60892678 | Sox3 | 853 | 0.435521 | 0.62 | 5.2e-07 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_108433472_108434154 | 33.48 |
Gm22942 |
predicted gene, 22942 |
7517 |
0.09 |
chr3_40070102_40070729 | 29.06 |
Gm42785 |
predicted gene 42785 |
246838 |
0.02 |
chr3_16819324_16819513 | 27.68 |
Gm26485 |
predicted gene, 26485 |
3894 |
0.38 |
chr6_55791826_55792546 | 27.40 |
Itprid1 |
ITPR interacting domain containing 1 |
44709 |
0.18 |
chr7_31149516_31150411 | 26.02 |
G630030J09Rik |
RIKEN cDNA G630030J09 gene |
435 |
0.6 |
chr15_66239660_66240017 | 25.96 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
46213 |
0.14 |
chr10_29143863_29144732 | 25.81 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr4_3082761_3083956 | 25.20 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
21234 |
0.18 |
chr13_54874229_54874840 | 24.45 |
Gm29431 |
predicted gene 29431 |
12936 |
0.13 |
chr15_91018414_91018934 | 24.38 |
Kif21a |
kinesin family member 21A |
31144 |
0.16 |
chr4_22835787_22836371 | 23.69 |
Gm24078 |
predicted gene, 24078 |
88948 |
0.09 |
chr4_122998402_122999232 | 23.68 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
63 |
0.96 |
chr1_172349913_172350109 | 23.30 |
Kcnj10 |
potassium inwardly-rectifying channel, subfamily J, member 10 |
8801 |
0.11 |
chr3_127294086_127294512 | 22.86 |
Gm42970 |
predicted gene 42970 |
5374 |
0.15 |
chr8_65617940_65618821 | 22.63 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr1_78190714_78190948 | 22.10 |
Pax3 |
paired box 3 |
6007 |
0.24 |
chr14_66494473_66494955 | 22.08 |
Gm23899 |
predicted gene, 23899 |
96981 |
0.07 |
chr18_33890616_33890776 | 21.71 |
Epb41l4a |
erythrocyte membrane protein band 4.1 like 4a |
943 |
0.66 |
chr4_3051990_3053232 | 21.70 |
Gm27878 |
predicted gene, 27878 |
792 |
0.7 |
chr13_85773910_85774095 | 21.49 |
Gm47636 |
predicted gene, 47636 |
91331 |
0.09 |
chr2_21010740_21011090 | 21.43 |
Gm13375 |
predicted gene 13375 |
41861 |
0.14 |
chr7_4123736_4124170 | 21.40 |
Ttyh1 |
tweety family member 1 |
536 |
0.57 |
chr1_51617502_51617987 | 21.37 |
Gm17767 |
predicted gene, 17767 |
21026 |
0.21 |
chr12_3236518_3237725 | 21.24 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr6_144313023_144313448 | 21.18 |
Sox5 |
SRY (sex determining region Y)-box 5 |
103667 |
0.08 |
chr11_32157683_32158170 | 21.13 |
Gm12109 |
predicted gene 12109 |
27079 |
0.12 |
chr13_83749857_83750036 | 20.95 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11083 |
0.12 |
chr7_62416271_62416450 | 20.57 |
Mkrn3 |
makorin, ring finger protein, 3 |
3779 |
0.19 |
chr6_22794374_22794759 | 20.45 |
Gm25942 |
predicted gene, 25942 |
4748 |
0.17 |
chr12_98573417_98573836 | 20.44 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
1086 |
0.43 |
chr6_54554355_54554906 | 20.29 |
Scrn1 |
secernin 1 |
175 |
0.95 |
chr13_84059669_84060031 | 20.24 |
Gm17750 |
predicted gene, 17750 |
4922 |
0.24 |
chr13_83885160_83885448 | 20.13 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
5904 |
0.23 |
chr15_73021189_73021788 | 19.98 |
Trappc9 |
trafficking protein particle complex 9 |
34322 |
0.18 |
chr16_77852087_77852674 | 19.81 |
Gm17333 |
predicted gene, 17333 |
5776 |
0.27 |
chr4_72233972_72234136 | 19.80 |
C630043F03Rik |
RIKEN cDNA C630043F03 gene |
32706 |
0.18 |
chr13_84449354_84449551 | 19.72 |
Gm26927 |
predicted gene, 26927 |
109339 |
0.06 |
chr13_25750886_25751367 | 19.72 |
Gm11350 |
predicted gene 11350 |
69983 |
0.13 |
chr16_37990629_37991083 | 19.63 |
Gm25140 |
predicted gene, 25140 |
10769 |
0.21 |
chr9_52223852_52224218 | 19.52 |
Zc3h12c |
zinc finger CCCH type containing 12C |
55463 |
0.12 |
chr13_113918235_113918418 | 19.34 |
Arl15 |
ADP-ribosylation factor-like 15 |
123704 |
0.05 |
chr18_81251894_81252538 | 19.32 |
Gm30192 |
predicted gene, 30192 |
12475 |
0.22 |
chr10_29143551_29143727 | 19.22 |
Soga3 |
SOGA family member 3 |
200 |
0.8 |
chr8_70119396_70119618 | 19.00 |
Ncan |
neurocan |
1366 |
0.21 |
chr2_150735739_150736543 | 18.98 |
Gm28450 |
predicted gene 28450 |
11520 |
0.12 |
chrX_143654722_143655126 | 18.93 |
Pak3 |
p21 (RAC1) activated kinase 3 |
9366 |
0.3 |
chr3_158062143_158062492 | 18.82 |
Lrrc40 |
leucine rich repeat containing 40 |
39 |
0.97 |
chr10_80300858_80301038 | 18.80 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
86 |
0.91 |
chr6_81660570_81661025 | 18.75 |
Gm26264 |
predicted gene, 26264 |
22486 |
0.22 |
chr7_73196833_73197263 | 18.73 |
Gm20083 |
predicted gene, 20083 |
11245 |
0.16 |
chr2_141074597_141074768 | 18.66 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
50620 |
0.15 |
chr19_12488103_12488765 | 18.60 |
Dtx4 |
deltex 4, E3 ubiquitin ligase |
13020 |
0.1 |
chr9_36821327_36821662 | 18.56 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
370 |
0.82 |
chr3_17796321_17796503 | 18.46 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
668 |
0.46 |
chr17_88494469_88494803 | 18.43 |
Ppp1r21 |
protein phosphatase 1, regulatory subunit 21 |
35482 |
0.13 |
chr13_71148802_71148994 | 18.43 |
Mir466f-4 |
microRNA 466f-4 |
41809 |
0.19 |
chr3_6106672_6106878 | 18.42 |
Gm17934 |
predicted gene, 17934 |
31469 |
0.2 |
chr18_16037927_16038695 | 18.40 |
Gm4835 |
predicted pseudogene 4835 |
49943 |
0.17 |
chr14_16200666_16200873 | 18.26 |
Rpl31-ps3 |
ribosomal protein L31, pseudogene 3 |
24254 |
0.13 |
chr5_146592655_146592919 | 18.17 |
Gm34333 |
predicted gene, 34333 |
7315 |
0.13 |
chr9_13652356_13652901 | 18.10 |
Maml2 |
mastermind like transcriptional coactivator 2 |
9832 |
0.2 |
chr4_100973634_100974412 | 18.05 |
Cachd1 |
cache domain containing 1 |
20588 |
0.19 |
chr19_17492246_17492464 | 18.03 |
Rfk |
riboflavin kinase |
94918 |
0.08 |
chr10_106609605_106610022 | 18.01 |
4930532I03Rik |
RIKEN cDNA 4930532I03 gene |
7333 |
0.29 |
chr4_107835452_107835981 | 17.94 |
Lrp8 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
4731 |
0.12 |
chr10_81364518_81366962 | 17.91 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr14_54332194_54332698 | 17.85 |
Gm3945 |
predicted gene 3945 |
1771 |
0.19 |
chr14_103764083_103764411 | 17.79 |
Slain1os |
SLAIN motif family, member 1, opposite strand |
64805 |
0.11 |
chr8_12947304_12948554 | 17.73 |
Mcf2l |
mcf.2 transforming sequence-like |
10 |
0.49 |
chr5_37245988_37246869 | 17.70 |
Crmp1 |
collapsin response mediator protein 1 |
583 |
0.76 |
chr2_180889406_180890514 | 17.66 |
Gm14342 |
predicted gene 14342 |
300 |
0.8 |
chr2_106454665_106455019 | 17.64 |
Gm14015 |
predicted gene 14015 |
68261 |
0.11 |
chr13_83741584_83742060 | 17.56 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2959 |
0.16 |
chr16_90522093_90522383 | 17.44 |
Gm36001 |
predicted gene, 36001 |
28371 |
0.14 |
chr6_89613728_89614091 | 17.41 |
Chchd6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
18257 |
0.17 |
chr8_41054492_41054681 | 17.41 |
Mtus1 |
mitochondrial tumor suppressor 1 |
197 |
0.91 |
chr6_55920513_55920755 | 17.37 |
Itprid1 |
ITPR interacting domain containing 1 |
33809 |
0.21 |
chr10_23674681_23675112 | 17.35 |
4930520K02Rik |
RIKEN cDNA 4930520K02 gene |
52748 |
0.11 |
chr2_122708149_122708787 | 17.34 |
4930417H01Rik |
RIKEN cDNA 4930417H01 gene |
425 |
0.78 |
chr15_13392917_13393530 | 17.33 |
Gm8238 |
predicted gene 8238 |
25633 |
0.22 |
chr7_79497714_79498195 | 17.20 |
Mir9-3hg |
Mir9-3 host gene |
2072 |
0.16 |
chr4_3067329_3068553 | 17.19 |
Gm27878 |
predicted gene, 27878 |
16122 |
0.2 |
chr2_165136026_165136418 | 17.16 |
Gm14397 |
predicted gene 14397 |
23190 |
0.14 |
chr15_24567016_24567356 | 17.16 |
Gm48920 |
predicted gene, 48920 |
38292 |
0.19 |
chr13_57603438_57603669 | 17.12 |
Spock1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 |
304034 |
0.01 |
chr13_8333561_8334203 | 16.89 |
Gm48260 |
predicted gene, 48260 |
34739 |
0.14 |
chr3_17785697_17785901 | 16.88 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
4122 |
0.22 |
chr3_108409761_108410771 | 16.85 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
5286 |
0.1 |
chr19_21789708_21790094 | 16.84 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
11513 |
0.21 |
chr9_41697271_41698297 | 16.47 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr7_62415346_62415506 | 16.40 |
Mkrn3 |
makorin, ring finger protein, 3 |
4713 |
0.18 |
chr1_126865602_126865808 | 16.35 |
4930599A14Rik |
RIKEN cDNA 4930599A14 gene |
10884 |
0.26 |
chr11_32087496_32088333 | 16.32 |
Gm12108 |
predicted gene 12108 |
13314 |
0.2 |
chr1_165966574_165966940 | 16.30 |
Gm17976 |
predicted gene, 17976 |
25139 |
0.13 |
chr2_21010157_21010628 | 16.26 |
Gm13375 |
predicted gene 13375 |
41338 |
0.14 |
chr2_152048577_152049360 | 16.23 |
AA387200 |
expressed sequence AA387200 |
27840 |
0.11 |
chr16_33605736_33606716 | 16.20 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr6_63911299_63911450 | 16.06 |
Gm44075 |
predicted gene, 44075 |
127307 |
0.05 |
chr14_70659174_70659883 | 16.04 |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
284 |
0.85 |
chr19_33049205_33049364 | 16.04 |
Gm29863 |
predicted gene, 29863 |
20788 |
0.21 |
chr14_119513370_119513775 | 16.02 |
Gm6212 |
predicted gene 6212 |
130440 |
0.05 |
chr17_52602043_52602770 | 16.01 |
Gm27217 |
predicted gene 27217 |
254 |
0.55 |
chr10_80145825_80146996 | 16.01 |
Midn |
midnolin |
1862 |
0.15 |
chr3_66325480_66326023 | 15.96 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
28914 |
0.18 |
chr8_48458356_48458774 | 15.96 |
Tenm3 |
teneurin transmembrane protein 3 |
96748 |
0.08 |
chr13_39523613_39524251 | 15.89 |
Gm47351 |
predicted gene, 47351 |
9171 |
0.2 |
chr12_29871996_29872873 | 15.85 |
Myt1l |
myelin transcription factor 1-like |
20886 |
0.24 |
chr2_163195886_163196065 | 15.83 |
Tox2 |
TOX high mobility group box family member 2 |
7150 |
0.19 |
chr6_47239363_47240145 | 15.82 |
Cntnap2 |
contactin associated protein-like 2 |
4633 |
0.33 |
chr14_76772767_76773006 | 15.75 |
Gm30246 |
predicted gene, 30246 |
7941 |
0.19 |
chr2_146217850_146218904 | 15.74 |
Insm1 |
insulinoma-associated 1 |
3544 |
0.21 |
chr2_97543699_97543878 | 15.73 |
Lrrc4c |
leucine rich repeat containing 4C |
75699 |
0.11 |
chr1_187076651_187076802 | 15.69 |
Gm15508 |
predicted gene 15508 |
3391 |
0.17 |
chr14_78204129_78204297 | 15.64 |
Gm48959 |
predicted gene, 48959 |
4840 |
0.2 |
chr3_56955404_56955772 | 15.63 |
Gm22269 |
predicted gene, 22269 |
98562 |
0.08 |
chr6_142111761_142111926 | 15.61 |
Gm18159 |
predicted gene, 18159 |
1387 |
0.44 |
chr3_19406344_19406802 | 15.56 |
Pde7a |
phosphodiesterase 7A |
95251 |
0.07 |
chr6_61042953_61043250 | 15.56 |
Gm43892 |
predicted gene, 43892 |
1892 |
0.33 |
chr9_45663652_45664379 | 15.54 |
Dscaml1 |
DS cell adhesion molecule like 1 |
8822 |
0.19 |
chr2_174917610_174917806 | 15.50 |
Gm14616 |
predicted gene 14616 |
61419 |
0.09 |
chr7_79525861_79526321 | 15.48 |
Mir9-3hg |
Mir9-3 host gene |
1759 |
0.18 |
chr10_108701445_108701650 | 15.46 |
Gm5136 |
predicted gene 5136 |
1387 |
0.53 |
chr9_108825088_108825551 | 15.45 |
Gm37714 |
predicted gene, 37714 |
30 |
0.71 |
chr12_44403738_44404185 | 15.44 |
Gm48182 |
predicted gene, 48182 |
5829 |
0.21 |
chr13_12650037_12651101 | 15.43 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
181 |
0.91 |
chr15_84417749_84418106 | 15.39 |
Shisal1 |
shisa like 1 |
25770 |
0.18 |
chr4_12263404_12263560 | 15.39 |
Gm11846 |
predicted gene 11846 |
7917 |
0.21 |
chr12_108320572_108321271 | 15.35 |
4930478K11Rik |
RIKEN cDNA 4930478K11 gene |
7109 |
0.16 |
chr17_52601056_52601789 | 15.26 |
Gm27217 |
predicted gene 27217 |
1238 |
0.39 |
chr15_8781624_8782079 | 15.24 |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
71087 |
0.11 |
chr2_152050523_152051049 | 15.22 |
AA387200 |
expressed sequence AA387200 |
26022 |
0.12 |
chr8_123411336_123412017 | 15.17 |
Tubb3 |
tubulin, beta 3 class III |
86 |
0.91 |
chr2_53437450_53438022 | 15.13 |
Gm13501 |
predicted gene 13501 |
39249 |
0.2 |
chr2_105680597_105681214 | 15.13 |
Pax6 |
paired box 6 |
807 |
0.59 |
chr6_86028659_86028835 | 15.09 |
Add2 |
adducin 2 (beta) |
0 |
0.96 |
chr18_25538633_25539394 | 15.04 |
Celf4 |
CUGBP, Elav-like family member 4 |
37774 |
0.19 |
chr1_162832222_162832528 | 15.00 |
Fmo1 |
flavin containing monooxygenase 1 |
1902 |
0.32 |
chr4_22491895_22492228 | 14.99 |
Gm30731 |
predicted gene, 30731 |
1513 |
0.34 |
chr8_116053518_116053716 | 14.95 |
Gm45733 |
predicted gene 45733 |
81546 |
0.11 |
chr3_157321061_157321436 | 14.92 |
Gm22458 |
predicted gene, 22458 |
44750 |
0.14 |
chr3_139885937_139886924 | 14.89 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr10_127078401_127078887 | 14.87 |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
263 |
0.78 |
chr18_72949026_72949703 | 14.86 |
Gm31908 |
predicted gene, 31908 |
28274 |
0.23 |
chr14_79773979_79774403 | 14.82 |
Pcdh8 |
protocadherin 8 |
2879 |
0.2 |
chr6_6603963_6604155 | 14.82 |
Sem1 |
SEM1, 26S proteasome complex subunit |
25396 |
0.18 |
chr16_41551835_41552284 | 14.76 |
Lsamp |
limbic system-associated membrane protein |
18640 |
0.29 |
chr4_10973002_10973483 | 14.75 |
Rps11-ps3 |
ribosomal protein S11, pseudogene 3 |
26634 |
0.14 |
chr9_85487393_85487544 | 14.75 |
Gm25125 |
predicted gene, 25125 |
14734 |
0.21 |
chr5_9339592_9339787 | 14.72 |
Gm15733 |
predicted gene 15733 |
14070 |
0.19 |
chr12_13984177_13984402 | 14.55 |
Gm48479 |
predicted gene, 48479 |
28795 |
0.19 |
chr11_80315811_80316355 | 14.51 |
Rhbdl3 |
rhomboid like 3 |
3607 |
0.23 |
chr2_165043149_165043683 | 14.49 |
Ncoa5 |
nuclear receptor coactivator 5 |
8549 |
0.14 |
chr17_55445138_55445530 | 14.48 |
St6gal2 |
beta galactoside alpha 2,6 sialyltransferase 2 |
48 |
0.98 |
chr2_28525282_28526472 | 14.48 |
Ralgds |
ral guanine nucleotide dissociation stimulator |
1973 |
0.2 |
chr9_10269473_10269801 | 14.46 |
Gm24496 |
predicted gene, 24496 |
20950 |
0.22 |
chr2_146324969_146325239 | 14.44 |
Gm14117 |
predicted gene 14117 |
19557 |
0.21 |
chr14_54475543_54476919 | 14.43 |
Rem2 |
rad and gem related GTP binding protein 2 |
9 |
0.95 |
chr4_137765336_137765990 | 14.38 |
Alpl |
alkaline phosphatase, liver/bone/kidney |
812 |
0.64 |
chr4_39345030_39345334 | 14.38 |
Gm23607 |
predicted gene, 23607 |
49719 |
0.14 |
chr15_67245652_67245820 | 14.37 |
1700012I11Rik |
RIKEN cDNA 1700012I11 gene |
18967 |
0.26 |
chr12_54034761_54035094 | 14.35 |
1700060O08Rik |
RIKEN cDNA 1700060O08 gene |
44465 |
0.17 |
chr4_100974528_100974984 | 14.33 |
Cachd1 |
cache domain containing 1 |
19855 |
0.19 |
chr13_83988136_83988456 | 14.30 |
Gm4241 |
predicted gene 4241 |
305 |
0.91 |
chr10_38553365_38553786 | 14.30 |
Gm22911 |
predicted gene, 22911 |
61906 |
0.14 |
chr3_102979946_102980141 | 14.30 |
Sike1 |
suppressor of IKBKE 1 |
15665 |
0.12 |
chr14_104298418_104298592 | 14.22 |
D130079A08Rik |
RIKEN cDNA D130079A08 gene |
160811 |
0.04 |
chr6_66399103_66399403 | 14.19 |
Gm44233 |
predicted gene, 44233 |
507 |
0.47 |
chr1_73850653_73851025 | 14.18 |
Mir6351 |
microRNA 6351 |
4736 |
0.19 |
chr1_88668916_88669101 | 14.16 |
Gm29336 |
predicted gene 29336 |
12700 |
0.16 |
chr4_22301616_22301795 | 14.15 |
Gm11882 |
predicted gene 11882 |
25872 |
0.19 |
chr13_84783122_84783632 | 14.15 |
Gm26913 |
predicted gene, 26913 |
92436 |
0.09 |
chr10_14703965_14704119 | 14.14 |
Vta1 |
vesicle (multivesicular body) trafficking 1 |
1417 |
0.28 |
chr12_118719970_118720143 | 14.07 |
Gm18441 |
predicted gene, 18441 |
12999 |
0.21 |
chr11_19523869_19524493 | 14.04 |
Gm12027 |
predicted gene 12027 |
103880 |
0.07 |
chr10_49322572_49322749 | 14.03 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
49855 |
0.15 |
chr2_27301445_27301810 | 13.97 |
Vav2 |
vav 2 oncogene |
22748 |
0.14 |
chr12_103313912_103314439 | 13.93 |
Gm29508 |
predicted gene 29508 |
170 |
0.86 |
chr3_4546148_4546485 | 13.90 |
Gm22944 |
predicted gene, 22944 |
21019 |
0.21 |
chr12_90132535_90132958 | 13.88 |
Gm48700 |
predicted gene, 48700 |
64647 |
0.14 |
chr18_26753599_26753876 | 13.86 |
Gm49976 |
predicted gene, 49976 |
164360 |
0.04 |
chr11_112860810_112861146 | 13.86 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
35799 |
0.18 |
chr13_93753079_93753280 | 13.85 |
Arsb |
arylsulfatase B |
18451 |
0.12 |
chr18_88784619_88784770 | 13.85 |
Socs6 |
suppressor of cytokine signaling 6 |
26203 |
0.17 |
chr3_17787193_17787344 | 13.85 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
2653 |
0.26 |
chr4_86183702_86183912 | 13.82 |
Adamtsl1 |
ADAMTS-like 1 |
15510 |
0.29 |
chr11_24307947_24308220 | 13.80 |
Gm12065 |
predicted gene 12065 |
105459 |
0.06 |
chr3_88205532_88206477 | 13.73 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr3_154468142_154468345 | 13.72 |
Tyw3 |
tRNA-yW synthesizing protein 3 homolog (S. cerevisiae) |
126291 |
0.05 |
chr16_16559483_16559649 | 13.67 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
424 |
0.84 |
chr19_28088001_28088445 | 13.51 |
Gm28228 |
predicted gene 28228 |
633 |
0.76 |
chr12_46075749_46076236 | 13.50 |
Gm24948 |
predicted gene, 24948 |
91649 |
0.09 |
chr14_100374770_100375216 | 13.48 |
Gm26367 |
predicted gene, 26367 |
43490 |
0.15 |
chr12_80061788_80062584 | 13.44 |
Gm36660 |
predicted gene, 36660 |
19248 |
0.14 |
chr4_107830742_107830914 | 13.41 |
Lrp8os1 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor, opposite strand 1 |
16 |
0.63 |
chr17_88325380_88326352 | 13.40 |
Gm22542 |
predicted gene, 22542 |
16616 |
0.17 |
chr3_128546488_128546865 | 13.39 |
Gm22293 |
predicted gene, 22293 |
6304 |
0.29 |
chr14_66319706_66319909 | 13.35 |
Gm41183 |
predicted gene, 41183 |
21422 |
0.13 |
chr18_17612349_17612583 | 13.33 |
4930545E07Rik |
RIKEN cDNA 4930545E07 gene |
31476 |
0.22 |
chr13_18281120_18281485 | 13.31 |
Pou6f2 |
POU domain, class 6, transcription factor 2 |
94816 |
0.08 |
chr4_111444284_111444825 | 13.29 |
Bend5 |
BEN domain containing 5 |
11235 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.1 | 48.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
11.7 | 35.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
10.3 | 41.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
8.8 | 78.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
8.0 | 23.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
7.8 | 70.6 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
7.7 | 23.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
7.1 | 21.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
6.9 | 34.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
6.3 | 43.9 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
6.1 | 18.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
6.1 | 12.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
6.0 | 29.9 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
5.8 | 23.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
5.7 | 17.0 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
5.6 | 16.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
5.6 | 16.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
5.6 | 22.5 | GO:0060486 | Clara cell differentiation(GO:0060486) |
5.3 | 21.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
5.3 | 21.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
5.2 | 10.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
5.2 | 36.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
5.1 | 35.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
5.0 | 15.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
4.9 | 14.8 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
4.9 | 14.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
4.9 | 14.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
4.8 | 19.3 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
4.8 | 9.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
4.8 | 14.3 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
4.6 | 13.7 | GO:0007412 | axon target recognition(GO:0007412) |
4.5 | 18.1 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
4.4 | 13.1 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
4.3 | 17.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
4.3 | 38.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
4.3 | 17.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
4.3 | 12.8 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
4.2 | 46.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
4.2 | 16.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
4.2 | 12.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
4.2 | 25.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
4.1 | 24.8 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
4.1 | 12.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
4.1 | 4.1 | GO:1902896 | terminal web assembly(GO:1902896) |
4.1 | 4.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
4.1 | 12.3 | GO:0030070 | insulin processing(GO:0030070) |
4.0 | 4.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
4.0 | 56.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
4.0 | 11.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
3.9 | 31.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
3.9 | 3.9 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
3.9 | 7.8 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
3.9 | 7.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
3.8 | 7.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
3.8 | 7.6 | GO:0098597 | observational learning(GO:0098597) |
3.8 | 15.1 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
3.8 | 11.3 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
3.7 | 11.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
3.7 | 7.4 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
3.6 | 10.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
3.6 | 10.8 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
3.6 | 10.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
3.6 | 7.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
3.5 | 3.5 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
3.5 | 7.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
3.5 | 13.8 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
3.5 | 10.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
3.5 | 10.4 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
3.4 | 3.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
3.3 | 9.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
3.3 | 6.5 | GO:0021764 | amygdala development(GO:0021764) |
3.3 | 19.5 | GO:0048840 | otolith development(GO:0048840) |
3.2 | 6.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
3.2 | 25.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
3.2 | 54.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
3.2 | 6.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
3.2 | 9.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
3.2 | 6.4 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
3.1 | 49.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
3.1 | 24.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
3.1 | 9.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
3.0 | 9.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
3.0 | 3.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
3.0 | 3.0 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
3.0 | 9.0 | GO:0014029 | neural crest formation(GO:0014029) |
2.9 | 11.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.9 | 8.8 | GO:0061743 | motor learning(GO:0061743) |
2.9 | 11.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.9 | 8.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.9 | 11.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.9 | 40.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
2.8 | 5.7 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
2.8 | 48.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
2.8 | 11.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.8 | 8.4 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.8 | 2.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.8 | 5.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.7 | 8.2 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
2.7 | 2.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
2.7 | 8.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.7 | 2.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
2.7 | 10.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
2.7 | 8.1 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
2.7 | 8.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
2.6 | 10.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
2.6 | 18.5 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
2.6 | 10.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
2.6 | 5.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
2.6 | 20.6 | GO:0060539 | diaphragm development(GO:0060539) |
2.6 | 12.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.6 | 7.7 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
2.6 | 2.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
2.5 | 5.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
2.5 | 7.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
2.5 | 5.1 | GO:0051665 | membrane raft localization(GO:0051665) |
2.5 | 22.8 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
2.5 | 7.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.5 | 10.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
2.5 | 7.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.5 | 5.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
2.5 | 12.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
2.5 | 9.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
2.5 | 7.5 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
2.5 | 2.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.5 | 14.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.5 | 22.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
2.4 | 9.8 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
2.4 | 7.3 | GO:0006868 | glutamine transport(GO:0006868) |
2.4 | 7.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
2.4 | 14.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
2.4 | 16.9 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
2.4 | 2.4 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
2.4 | 7.2 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
2.4 | 7.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
2.4 | 28.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
2.3 | 9.4 | GO:0030035 | microspike assembly(GO:0030035) |
2.3 | 7.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
2.3 | 11.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
2.3 | 23.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
2.3 | 4.7 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
2.3 | 16.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
2.3 | 2.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
2.3 | 9.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
2.3 | 2.3 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
2.3 | 4.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
2.3 | 2.3 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
2.2 | 22.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
2.2 | 4.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.2 | 17.8 | GO:0071625 | vocalization behavior(GO:0071625) |
2.2 | 13.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
2.2 | 13.3 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
2.2 | 2.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.2 | 15.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
2.2 | 4.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
2.2 | 19.4 | GO:0008038 | neuron recognition(GO:0008038) |
2.1 | 8.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
2.1 | 19.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
2.1 | 6.4 | GO:0030421 | defecation(GO:0030421) |
2.1 | 29.6 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
2.1 | 6.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
2.1 | 8.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
2.1 | 6.2 | GO:0001927 | exocyst assembly(GO:0001927) |
2.1 | 2.1 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
2.1 | 12.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
2.0 | 10.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
2.0 | 4.1 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
2.0 | 12.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
2.0 | 2.0 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
2.0 | 23.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.0 | 35.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.0 | 3.9 | GO:0021544 | subpallium development(GO:0021544) |
1.9 | 3.9 | GO:0097503 | sialylation(GO:0097503) |
1.9 | 1.9 | GO:1902946 | protein localization to early endosome(GO:1902946) |
1.9 | 7.6 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.9 | 3.8 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.9 | 3.8 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
1.9 | 7.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.9 | 5.6 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
1.9 | 16.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.8 | 5.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.8 | 3.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.8 | 5.5 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.8 | 1.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.8 | 5.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.8 | 10.9 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.8 | 7.2 | GO:0022038 | corpus callosum development(GO:0022038) |
1.8 | 26.9 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
1.8 | 5.4 | GO:0060005 | vestibular reflex(GO:0060005) |
1.8 | 8.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.8 | 3.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.8 | 10.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.8 | 5.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.8 | 3.5 | GO:0060166 | olfactory pit development(GO:0060166) |
1.8 | 5.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.7 | 8.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.7 | 5.2 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.7 | 1.7 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
1.7 | 3.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.7 | 5.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.7 | 5.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.7 | 1.7 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.7 | 3.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
1.6 | 4.9 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
1.6 | 1.6 | GO:0048880 | sensory system development(GO:0048880) |
1.6 | 14.7 | GO:0060384 | innervation(GO:0060384) |
1.6 | 4.9 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
1.6 | 26.1 | GO:0001964 | startle response(GO:0001964) |
1.6 | 6.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.6 | 3.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.6 | 1.6 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
1.6 | 7.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.6 | 3.2 | GO:0042428 | serotonin metabolic process(GO:0042428) |
1.6 | 4.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.6 | 3.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.6 | 3.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.6 | 113.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.5 | 3.1 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
1.5 | 3.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.5 | 9.2 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
1.5 | 72.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.5 | 39.9 | GO:0019228 | neuronal action potential(GO:0019228) |
1.5 | 4.6 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
1.5 | 22.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
1.5 | 1.5 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
1.5 | 3.0 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
1.5 | 1.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.5 | 4.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.5 | 5.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.5 | 10.2 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.5 | 4.4 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.4 | 1.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.4 | 8.6 | GO:0060179 | male mating behavior(GO:0060179) |
1.4 | 4.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.4 | 2.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.4 | 5.7 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.4 | 5.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
1.4 | 5.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.4 | 4.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.4 | 2.8 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.4 | 13.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.4 | 2.8 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.4 | 4.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.4 | 12.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
1.4 | 4.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.4 | 2.7 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.4 | 23.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.4 | 5.4 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.4 | 1.4 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.4 | 2.7 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.3 | 9.4 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.3 | 5.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.3 | 5.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.3 | 4.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.3 | 6.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.3 | 7.9 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.3 | 9.2 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
1.3 | 3.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.3 | 12.9 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
1.3 | 1.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.3 | 2.6 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
1.3 | 7.7 | GO:0006108 | malate metabolic process(GO:0006108) |
1.3 | 5.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
1.2 | 20.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.2 | 6.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
1.2 | 4.9 | GO:0010042 | response to manganese ion(GO:0010042) |
1.2 | 3.7 | GO:0021794 | thalamus development(GO:0021794) |
1.2 | 2.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.2 | 2.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.2 | 7.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.2 | 1.2 | GO:0048382 | mesendoderm development(GO:0048382) |
1.2 | 3.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.2 | 6.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.2 | 2.4 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
1.2 | 3.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.2 | 9.4 | GO:0070986 | left/right axis specification(GO:0070986) |
1.2 | 8.2 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.2 | 1.2 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
1.2 | 2.3 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
1.2 | 1.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
1.2 | 2.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.2 | 2.3 | GO:0090135 | actin filament branching(GO:0090135) |
1.2 | 2.3 | GO:0072172 | mesonephric tubule formation(GO:0072172) |
1.2 | 2.3 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
1.1 | 9.2 | GO:0015816 | glycine transport(GO:0015816) |
1.1 | 2.3 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
1.1 | 4.6 | GO:0015808 | L-alanine transport(GO:0015808) |
1.1 | 5.7 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.1 | 3.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.1 | 17.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.1 | 1.1 | GO:0021557 | oculomotor nerve development(GO:0021557) |
1.1 | 1.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.1 | 5.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.1 | 4.5 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
1.1 | 2.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.1 | 1.1 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.1 | 3.3 | GO:0090427 | activation of meiosis(GO:0090427) |
1.1 | 7.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
1.1 | 3.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.1 | 4.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.1 | 6.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.1 | 2.2 | GO:0019230 | proprioception(GO:0019230) |
1.1 | 3.2 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
1.1 | 2.1 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
1.1 | 3.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.1 | 3.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
1.1 | 5.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.1 | 5.3 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
1.1 | 1.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.1 | 1.1 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.1 | 9.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
1.1 | 3.2 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
1.1 | 1.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
1.1 | 6.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.1 | 2.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.1 | 40.0 | GO:0046847 | filopodium assembly(GO:0046847) |
1.1 | 2.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
1.0 | 3.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.0 | 2.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.0 | 1.0 | GO:0030432 | peristalsis(GO:0030432) |
1.0 | 5.2 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
1.0 | 5.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.0 | 6.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.0 | 2.1 | GO:0071673 | regulation of smooth muscle cell chemotaxis(GO:0071671) positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.0 | 3.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.0 | 2.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.0 | 2.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
1.0 | 4.1 | GO:0021854 | hypothalamus development(GO:0021854) |
1.0 | 5.1 | GO:0060068 | vagina development(GO:0060068) |
1.0 | 4.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.0 | 3.0 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.0 | 5.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.0 | 1.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
1.0 | 3.0 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.0 | 1.0 | GO:2000018 | regulation of male gonad development(GO:2000018) |
1.0 | 6.0 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
1.0 | 5.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
1.0 | 1.0 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
1.0 | 12.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.0 | 1.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
1.0 | 2.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
1.0 | 2.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.0 | 27.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.0 | 1.9 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.0 | 1.0 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
1.0 | 4.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
1.0 | 1.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.0 | 1.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.9 | 3.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.9 | 2.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.9 | 2.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.9 | 3.7 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.9 | 17.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.9 | 0.9 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.9 | 2.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.9 | 1.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.9 | 4.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.9 | 20.0 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.9 | 1.8 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.9 | 2.7 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.9 | 1.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.9 | 0.9 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.9 | 1.8 | GO:0048664 | neuron fate determination(GO:0048664) |
0.9 | 2.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.9 | 3.6 | GO:0060437 | lung growth(GO:0060437) |
0.9 | 0.9 | GO:0035973 | aggrephagy(GO:0035973) |
0.9 | 1.8 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.9 | 2.7 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.9 | 3.5 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.9 | 4.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.9 | 0.9 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.9 | 3.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.9 | 3.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.9 | 2.6 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.9 | 1.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.9 | 2.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.9 | 2.6 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.9 | 2.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.9 | 3.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.9 | 1.7 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.9 | 2.6 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.9 | 9.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.8 | 1.7 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.8 | 2.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.8 | 2.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.8 | 1.7 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.8 | 3.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.8 | 3.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.8 | 1.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.8 | 6.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.8 | 0.8 | GO:0042891 | antibiotic transport(GO:0042891) |
0.8 | 4.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.8 | 8.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.8 | 4.9 | GO:0015074 | DNA integration(GO:0015074) |
0.8 | 2.4 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.8 | 2.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.8 | 3.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.8 | 9.8 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.8 | 2.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.8 | 2.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.8 | 1.6 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.8 | 3.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.8 | 1.6 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.8 | 4.0 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.8 | 2.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.8 | 4.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.8 | 4.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.8 | 2.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.8 | 0.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.8 | 3.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.8 | 6.3 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.8 | 4.7 | GO:0060736 | prostate gland growth(GO:0060736) |
0.8 | 2.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.8 | 2.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.8 | 1.5 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.8 | 3.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.8 | 2.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.8 | 1.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.8 | 0.8 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.8 | 0.8 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.8 | 6.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.8 | 3.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.8 | 3.0 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.8 | 1.5 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.8 | 5.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.8 | 0.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.8 | 3.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.7 | 0.7 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
0.7 | 2.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.7 | 10.4 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.7 | 1.5 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.7 | 3.0 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.7 | 2.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.7 | 2.9 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.7 | 0.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.7 | 6.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 2.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.7 | 3.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.7 | 2.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.7 | 3.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.7 | 2.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 2.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.7 | 2.9 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.7 | 1.4 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.7 | 7.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.7 | 1.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.7 | 1.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.7 | 10.5 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.7 | 2.1 | GO:0030242 | pexophagy(GO:0030242) |
0.7 | 2.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.7 | 2.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.7 | 2.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 | 11.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.7 | 2.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.7 | 1.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.7 | 0.7 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.7 | 3.4 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.7 | 4.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.7 | 1.3 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.7 | 3.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.7 | 3.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.7 | 8.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.7 | 5.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.7 | 7.3 | GO:0007416 | synapse assembly(GO:0007416) |
0.7 | 0.7 | GO:0002339 | B cell selection(GO:0002339) |
0.7 | 2.0 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.6 | 2.6 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.6 | 1.9 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.6 | 0.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.6 | 2.5 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.6 | 1.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.6 | 1.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.6 | 2.5 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.6 | 1.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.6 | 4.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.6 | 0.6 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.6 | 3.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.6 | 11.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.6 | 33.1 | GO:0007612 | learning(GO:0007612) |
0.6 | 8.6 | GO:0007616 | long-term memory(GO:0007616) |
0.6 | 17.1 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.6 | 1.8 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.6 | 2.4 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.6 | 2.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.6 | 0.6 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.6 | 3.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.6 | 0.6 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.6 | 0.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 6.5 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.6 | 1.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.6 | 0.6 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.6 | 0.6 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.6 | 0.6 | GO:0015817 | histidine transport(GO:0015817) |
0.6 | 1.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.6 | 1.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.6 | 0.6 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.6 | 1.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.6 | 0.6 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.6 | 1.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.6 | 1.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 1.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.6 | 2.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 2.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.5 | 5.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.5 | 0.5 | GO:0045472 | response to ether(GO:0045472) |
0.5 | 1.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 2.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.5 | 2.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 4.8 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.5 | 12.9 | GO:0007340 | acrosome reaction(GO:0007340) |
0.5 | 2.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.5 | 2.7 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.5 | 0.5 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.5 | 2.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.5 | 4.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.5 | 0.5 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.5 | 1.5 | GO:0090148 | membrane fission(GO:0090148) |
0.5 | 0.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.5 | 1.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.5 | 1.5 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.5 | 5.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.5 | 1.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.5 | 3.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.5 | 3.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 1.0 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.5 | 1.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.5 | 0.5 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.5 | 3.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 0.5 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.5 | 1.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 1.4 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.5 | 1.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.5 | 3.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.5 | 1.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 0.9 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.5 | 0.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.5 | 1.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.5 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.5 | 1.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.5 | 0.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.4 | 1.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 2.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.4 | 1.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 3.5 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.4 | 0.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.4 | 0.9 | GO:0014889 | muscle atrophy(GO:0014889) |
0.4 | 0.9 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.4 | 1.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.4 | 0.4 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.4 | 1.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 1.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.4 | 1.7 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.4 | 1.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.4 | 3.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 1.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.4 | 1.3 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.4 | 0.8 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.4 | 1.2 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.4 | 1.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.4 | 0.8 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.4 | 2.9 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.4 | 8.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.4 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.4 | 0.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.4 | 0.4 | GO:0007632 | visual behavior(GO:0007632) |
0.4 | 6.4 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.4 | 2.4 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.4 | 0.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 23.1 | GO:0007626 | locomotory behavior(GO:0007626) |
0.4 | 1.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 2.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.4 | 0.8 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.4 | 1.6 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.4 | 1.2 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.4 | 9.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.4 | 4.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.4 | 0.8 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.4 | 0.4 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.4 | 1.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.4 | 2.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.4 | 4.3 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.4 | 0.8 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.4 | 6.2 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.4 | 2.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.4 | 1.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.4 | 1.5 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.4 | 3.0 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.4 | 1.9 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.4 | 0.4 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.4 | 1.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.4 | 1.5 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.4 | 1.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.4 | 2.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 2.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.4 | 0.7 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.4 | 3.2 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.4 | 0.4 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.4 | 2.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.4 | 2.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.4 | 0.4 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 3.1 | GO:0097369 | sodium ion import(GO:0097369) |
0.3 | 1.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.3 | 0.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.3 | 0.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.3 | 0.7 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 1.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 1.0 | GO:0035878 | nail development(GO:0035878) |
0.3 | 3.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.3 | 0.3 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.3 | 2.3 | GO:0006266 | DNA ligation(GO:0006266) |
0.3 | 2.0 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 0.7 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.3 | 0.3 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.3 | 0.6 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 1.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.3 | 0.3 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 0.3 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.3 | 2.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 0.6 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 0.3 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.3 | 1.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 0.6 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.3 | 0.6 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.3 | 1.6 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 0.9 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 0.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.3 | 2.5 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.3 | 0.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 16.5 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.3 | 1.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 3.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 2.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.3 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 1.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.3 | 0.6 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.3 | 0.8 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 1.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.3 | 8.4 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.3 | 0.8 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 2.2 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.3 | 0.8 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.3 | 8.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.3 | 0.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 0.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 0.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 0.5 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.3 | 0.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 1.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.3 | 0.8 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.3 | 0.8 | GO:0046618 | drug export(GO:0046618) |
0.3 | 1.3 | GO:0021766 | hippocampus development(GO:0021766) |
0.3 | 1.0 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 0.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 0.3 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 3.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 1.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.7 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 2.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 0.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 1.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 2.4 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.7 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 1.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.7 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 0.7 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 1.2 | GO:1902583 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 1.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.2 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.2 | 0.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 1.4 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.2 | 2.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.2 | 1.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 1.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.2 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.2 | 1.5 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 1.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.8 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 0.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.4 | GO:0070268 | cornification(GO:0070268) |
0.2 | 1.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 0.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 1.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.8 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.6 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) positive regulation of enamel mineralization(GO:0070175) |
0.2 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.6 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 1.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.2 | 0.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 0.6 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 0.4 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.2 | 0.5 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.2 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.5 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 17.3 | GO:0006813 | potassium ion transport(GO:0006813) |
0.2 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 0.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 1.1 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.2 | 0.2 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.2 | 1.1 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.3 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 1.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.1 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 3.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.4 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.5 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 1.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.3 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.1 | 0.4 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.1 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.1 | GO:1904238 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.1 | 0.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.5 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.1 | GO:0070173 | regulation of tooth mineralization(GO:0070170) regulation of enamel mineralization(GO:0070173) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.4 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 1.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 1.2 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.1 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 0.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 1.7 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.5 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.1 | 0.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 1.3 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 1.1 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.3 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 1.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.1 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.1 | 0.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 1.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.1 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.3 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.1 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.1 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.3 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.5 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.1 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.0 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 4.7 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.0 | 0.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.0 | 0.6 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.0 | 0.0 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.0 | 0.0 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) |
0.0 | 0.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.0 | 0.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.2 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.0 | GO:0061308 | cardiac neural crest cell development involved in heart development(GO:0061308) cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.0 | GO:0033227 | dsRNA transport(GO:0033227) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.4 | 22.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
6.5 | 78.2 | GO:0043194 | axon initial segment(GO:0043194) |
5.7 | 34.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
5.4 | 48.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
5.4 | 69.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
4.9 | 14.8 | GO:0072534 | perineuronal net(GO:0072534) |
4.9 | 24.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
4.5 | 18.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
3.7 | 37.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
3.5 | 24.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
3.4 | 10.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
3.2 | 57.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
2.9 | 20.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.7 | 71.2 | GO:0044295 | axonal growth cone(GO:0044295) |
2.7 | 2.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
2.6 | 21.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
2.4 | 19.4 | GO:0071437 | invadopodium(GO:0071437) |
2.4 | 7.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.4 | 7.2 | GO:0048179 | activin receptor complex(GO:0048179) |
2.3 | 9.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
2.2 | 2.2 | GO:0097513 | myosin II filament(GO:0097513) |
2.2 | 6.7 | GO:0033010 | paranodal junction(GO:0033010) |
2.2 | 8.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.1 | 6.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.1 | 6.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
2.0 | 20.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.9 | 3.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.9 | 1.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.9 | 44.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.9 | 7.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.9 | 5.7 | GO:0097427 | microtubule bundle(GO:0097427) |
1.8 | 11.1 | GO:0032584 | growth cone membrane(GO:0032584) |
1.8 | 7.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.8 | 5.5 | GO:0042585 | germinal vesicle(GO:0042585) |
1.8 | 1.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.8 | 5.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.8 | 3.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.8 | 21.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.7 | 67.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.7 | 27.2 | GO:0030673 | axolemma(GO:0030673) |
1.7 | 11.8 | GO:0043083 | synaptic cleft(GO:0043083) |
1.7 | 97.6 | GO:0030175 | filopodium(GO:0030175) |
1.7 | 49.6 | GO:0031941 | filamentous actin(GO:0031941) |
1.6 | 4.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.6 | 21.8 | GO:0043196 | varicosity(GO:0043196) |
1.5 | 21.4 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.5 | 10.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.5 | 1.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.5 | 7.5 | GO:0097449 | astrocyte projection(GO:0097449) |
1.4 | 5.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.4 | 14.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.4 | 4.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.4 | 2.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.3 | 4.0 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
1.3 | 3.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.3 | 5.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.2 | 6.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.2 | 173.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.2 | 2.4 | GO:0097441 | basilar dendrite(GO:0097441) |
1.1 | 6.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.1 | 2.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
1.1 | 36.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.1 | 18.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.1 | 5.4 | GO:0071547 | piP-body(GO:0071547) |
1.1 | 5.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.1 | 4.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.1 | 11.8 | GO:0042555 | MCM complex(GO:0042555) |
1.0 | 6.2 | GO:0005915 | zonula adherens(GO:0005915) |
1.0 | 2.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.0 | 5.8 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.9 | 6.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.9 | 81.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.9 | 0.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.9 | 2.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.9 | 4.5 | GO:0097433 | dense body(GO:0097433) |
0.9 | 3.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.9 | 7.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.9 | 6.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.9 | 5.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.9 | 2.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.8 | 6.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.8 | 13.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.8 | 9.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.8 | 2.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.8 | 3.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.8 | 5.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.8 | 1.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.8 | 3.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.8 | 4.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.8 | 7.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.8 | 2.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.8 | 2.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.7 | 2.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.7 | 5.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 2.0 | GO:1990357 | terminal web(GO:1990357) |
0.7 | 0.7 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 2.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.7 | 5.3 | GO:0032797 | SMN complex(GO:0032797) |
0.6 | 1.9 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.6 | 3.7 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.6 | 1.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.6 | 29.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.6 | 2.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.6 | 0.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.6 | 26.4 | GO:0030426 | growth cone(GO:0030426) |
0.6 | 1.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.6 | 14.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.6 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 5.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 2.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 20.3 | GO:0098794 | postsynapse(GO:0098794) |
0.5 | 1.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.5 | 1.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.5 | 6.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 4.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.5 | 1.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 2.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 1.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.5 | 1.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.5 | 7.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 5.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.5 | 30.4 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 1.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.5 | 3.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 61.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 1.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 3.5 | GO:0060091 | kinocilium(GO:0060091) |
0.4 | 7.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.4 | 2.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 1.7 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 4.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.4 | 1.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.4 | 0.8 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 1.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 2.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 1.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 1.2 | GO:0000802 | transverse filament(GO:0000802) |
0.4 | 0.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 1.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 4.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 2.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 2.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 2.1 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 3.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 1.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 2.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 4.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 10.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 2.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.8 | GO:0002177 | manchette(GO:0002177) |
0.3 | 0.9 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 0.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 0.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 5.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 0.8 | GO:0036396 | MIS complex(GO:0036396) |
0.3 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 1.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 6.3 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 3.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 1.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 52.2 | GO:0030425 | dendrite(GO:0030425) |
0.2 | 1.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 1.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 3.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 0.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 0.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 2.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 1.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.2 | 0.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 2.8 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.0 | GO:1990745 | EARP complex(GO:1990745) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.6 | 73.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
8.7 | 26.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
8.2 | 24.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
7.9 | 39.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
6.4 | 32.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
6.4 | 25.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
6.2 | 30.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
5.7 | 17.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
5.5 | 16.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
5.5 | 16.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
5.3 | 21.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
4.6 | 22.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
4.5 | 9.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
4.5 | 17.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
4.4 | 13.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
4.3 | 12.9 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
4.2 | 29.1 | GO:0003680 | AT DNA binding(GO:0003680) |
4.1 | 8.1 | GO:0097016 | L27 domain binding(GO:0097016) |
4.0 | 12.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
4.0 | 11.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
4.0 | 11.9 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
3.8 | 15.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
3.7 | 15.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
3.5 | 20.8 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
3.4 | 13.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
3.3 | 13.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
3.3 | 9.9 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
3.2 | 35.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
3.2 | 22.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
3.2 | 16.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
3.1 | 6.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
3.1 | 15.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
3.0 | 9.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
3.0 | 9.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
3.0 | 12.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
3.0 | 9.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.9 | 8.8 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.9 | 66.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
2.9 | 8.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.8 | 31.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
2.8 | 11.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
2.8 | 2.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.7 | 10.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
2.7 | 16.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.7 | 16.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.6 | 5.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.6 | 34.0 | GO:0031005 | filamin binding(GO:0031005) |
2.6 | 12.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.6 | 35.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
2.5 | 10.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.4 | 2.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
2.4 | 2.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
2.4 | 2.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
2.4 | 21.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
2.2 | 11.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
2.2 | 4.4 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
2.2 | 8.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.2 | 10.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
2.2 | 41.2 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
2.1 | 12.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
2.1 | 16.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.0 | 8.2 | GO:0097001 | ceramide binding(GO:0097001) |
2.0 | 7.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.9 | 9.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.9 | 17.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.9 | 5.7 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.9 | 5.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.9 | 13.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.8 | 27.5 | GO:0031402 | sodium ion binding(GO:0031402) |
1.8 | 5.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.8 | 20.1 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
1.8 | 7.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.8 | 30.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.8 | 5.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.8 | 5.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.7 | 5.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.7 | 18.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.7 | 11.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.7 | 10.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.7 | 5.0 | GO:0035939 | microsatellite binding(GO:0035939) |
1.6 | 3.3 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
1.6 | 3.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.6 | 6.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.6 | 4.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.6 | 24.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.6 | 6.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
1.6 | 4.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.6 | 25.0 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.6 | 42.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.6 | 46.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.6 | 15.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.5 | 1.5 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
1.5 | 6.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
1.5 | 4.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.5 | 48.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.5 | 4.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.5 | 44.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.5 | 7.3 | GO:0048495 | Roundabout binding(GO:0048495) |
1.5 | 10.2 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.5 | 4.4 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.4 | 1.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
1.4 | 8.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.4 | 4.3 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
1.4 | 5.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.4 | 4.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.4 | 29.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.4 | 5.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.4 | 1.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.4 | 2.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.3 | 8.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.3 | 6.6 | GO:0016151 | nickel cation binding(GO:0016151) |
1.3 | 14.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.3 | 2.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.3 | 5.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.3 | 6.3 | GO:1990254 | keratin filament binding(GO:1990254) |
1.3 | 3.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.2 | 1.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.2 | 3.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.2 | 4.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.2 | 3.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.2 | 2.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
1.2 | 21.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.2 | 5.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.2 | 24.7 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.2 | 3.5 | GO:0004946 | bombesin receptor activity(GO:0004946) |
1.1 | 3.4 | GO:0018586 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
1.1 | 6.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.1 | 4.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.1 | 4.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.1 | 19.3 | GO:0005112 | Notch binding(GO:0005112) |
1.1 | 10.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.1 | 10.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.1 | 25.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.1 | 7.8 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.1 | 2.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.1 | 3.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.1 | 5.5 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
1.1 | 14.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.1 | 16.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.1 | 17.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.1 | 3.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.1 | 3.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.0 | 11.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
1.0 | 3.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.0 | 5.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.0 | 4.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.0 | 3.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.0 | 4.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.0 | 21.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
1.0 | 3.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.0 | 9.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.9 | 1.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.9 | 2.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.9 | 2.8 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.9 | 13.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.9 | 5.5 | GO:0002054 | nucleobase binding(GO:0002054) |
0.9 | 3.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.9 | 10.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.9 | 0.9 | GO:0003896 | DNA primase activity(GO:0003896) |
0.9 | 7.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.9 | 4.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.9 | 9.0 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.9 | 2.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.9 | 0.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.9 | 7.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.9 | 7.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.9 | 7.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.9 | 3.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.9 | 6.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.8 | 1.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.8 | 9.0 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 4.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.8 | 5.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.8 | 2.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.8 | 0.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.8 | 3.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.8 | 2.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.8 | 6.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 1.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.7 | 9.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.7 | 8.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.7 | 4.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.7 | 2.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.7 | 1.5 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.7 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.7 | 5.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.7 | 13.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.7 | 4.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.7 | 2.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.7 | 2.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.7 | 3.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.7 | 6.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.7 | 2.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.7 | 0.7 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.6 | 1.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.6 | 1.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.6 | 1.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.6 | 13.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.6 | 1.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 3.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.6 | 7.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.6 | 6.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.6 | 1.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.6 | 1.8 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.6 | 14.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.6 | 1.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 3.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.6 | 1.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.6 | 0.6 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.6 | 4.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.6 | 0.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.6 | 2.3 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 2.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.5 | 4.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.5 | 2.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.5 | 3.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.5 | 1.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.5 | 14.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 1.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.5 | 4.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.5 | 4.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 8.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 3.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 5.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.5 | 2.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.5 | 1.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.5 | 1.5 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.5 | 1.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.5 | 1.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 1.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 5.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 24.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.5 | 1.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.5 | 10.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 1.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.5 | 0.5 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 3.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 1.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.5 | 5.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.5 | 10.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 1.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 1.4 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 4.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.4 | 10.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.4 | 0.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 1.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 3.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 0.4 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.4 | 4.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 3.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.4 | 1.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 10.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 0.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.4 | 3.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.4 | 1.7 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.4 | 8.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 9.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 2.5 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.4 | 1.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.4 | 0.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 2.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 1.9 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 1.2 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 1.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 9.9 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 0.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.4 | 2.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.4 | 5.0 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.4 | 1.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 1.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 1.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 1.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.4 | 1.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 1.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 3.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 1.0 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 0.7 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.3 | 2.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 0.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 2.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 1.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 2.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 2.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 14.1 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.3 | 8.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 13.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.3 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 2.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.3 | 1.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 0.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 3.9 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 0.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 0.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 1.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 1.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 3.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 14.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.3 | 4.0 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 1.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 1.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 1.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 4.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 0.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 1.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.3 | 1.5 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 1.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 2.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 1.8 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 1.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 4.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 1.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 1.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.8 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 1.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.6 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 3.4 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 4.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 2.7 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 1.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 35.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 0.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.3 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 1.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 3.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 3.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.4 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 2.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.5 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 2.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 5.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 1.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.9 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.2 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 2.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 10.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 17.5 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.8 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 56.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
2.3 | 4.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
2.1 | 12.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.7 | 49.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.6 | 54.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.1 | 15.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.1 | 5.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.9 | 0.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.9 | 2.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.9 | 1.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.9 | 21.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.9 | 10.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.9 | 1.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.9 | 13.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.8 | 0.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 13.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.8 | 12.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 17.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.7 | 19.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.7 | 6.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.6 | 13.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 6.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 11.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 1.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 1.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 17.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.5 | 1.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 1.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 1.7 | ST ADRENERGIC | Adrenergic Pathway |
0.4 | 8.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.4 | 4.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 8.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 1.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 0.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 4.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 9.1 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 2.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 2.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 2.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 0.7 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 1.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 4.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 7.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.9 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 99.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.9 | 3.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
3.5 | 3.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
3.2 | 35.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.2 | 38.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
3.0 | 50.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.7 | 35.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
2.5 | 52.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.2 | 8.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.1 | 47.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.1 | 32.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.9 | 21.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.9 | 7.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
1.8 | 25.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.8 | 21.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.6 | 47.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.5 | 12.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.5 | 29.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.5 | 16.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.5 | 10.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.5 | 11.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.4 | 4.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.3 | 2.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.3 | 54.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.2 | 31.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.2 | 3.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.2 | 2.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.2 | 16.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.1 | 25.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.1 | 25.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.1 | 22.6 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
1.0 | 25.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.0 | 4.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.0 | 9.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.0 | 10.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.0 | 16.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
1.0 | 4.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.0 | 2.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.0 | 14.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.0 | 15.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.9 | 3.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.9 | 7.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.8 | 9.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.8 | 2.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.8 | 0.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.8 | 16.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.8 | 16.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.7 | 24.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.7 | 5.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.7 | 5.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.7 | 1.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.7 | 1.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.7 | 6.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 7.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 3.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 0.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.6 | 18.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 6.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.6 | 6.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.5 | 1.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.5 | 9.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 3.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 7.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 2.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 1.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.3 | 5.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 5.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 1.6 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.3 | 0.3 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.3 | 4.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 3.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 0.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 3.6 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.3 | 9.8 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.3 | 2.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 4.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 5.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 4.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 2.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 1.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 2.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 2.8 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.2 | 3.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 6.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 6.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.0 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.1 | REACTOME IMMUNE SYSTEM | Genes involved in Immune System |
0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |